✦ LIBER ✦

Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy

✍ Scribed by Linda Mesler Muul; Elaine P. Director; Cornelia L. Hyatt; Steven A. Rosenberg

Book ID: 118900111
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 640 KB
Volume: 88
Category: Article
ISSN: 0022-1759
DOI: 10.1016/0022-1759(86)90015-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of an automated closed syste

Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy

✍ Linda Mesler Muul; Kathryn Nason-Burchenal; Charles S. Carter; Herbert Cullis; D 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Adoptive immunotherapy for recurrent gli

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2

✍ Randall E. Merchant; Angus J. Grant; Lynn H. Merchant; Harold F. Young 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Thirteen patients with recurrent glioblastoma were treated with adoptively transferred autologous lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2). Patients' blood mononuclear cells (MNC) obtained by leukapheresis were cultured at 2.5 million MNC per ml for 3 to 5 days i

Adoptive immunotherapy for unresectable

Adoptive immunotherapy for unresectable or recurrent pancreatic cancer, using lymphokine-activated killer cells or cytotoxic T cells

✍ Oka, Masaaki ;Suzuki, Michinari ;Hazama, Shoichi ;Suzuki, Takashi 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 513 KB

Identification and expansion of human ly

Identification and expansion of human lymphokine-activated killer cells: Implications for the immunotherapy of cancer

✍ John M. Skibber; M.T. Lotze; I. Uppenkamp; W. Ross; S.A. Rosenberg 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 742 KB

A simplified automated procedure for gen

A simplified automated procedure for generation of human lymphokine-activated killer cells for use in clinical trials

✍ Paul Aebersold; Charles S. Carter; Cornelia Hyatt; Susan Johnson; Katherine Otta 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 451 KB

Augmentation by Tumor Necrosis Factor α

Augmentation by Tumor Necrosis Factor α of the Systemic Therapeutic Effect of Lymphokine-activated Killer Cells in Adoptive Immunotherapy of Murine Tumor

✍ Kato, Kazunori ;Tanabe, Toshifumi ;Agatsuma, Toshinori ;Suzuki, Shinya ;Nitanai, 📂 Article 📅 1991 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 392 KB